Podcast

Treating Waldenstrom’s Macroglobulinemia

Author(s):

Kristie L. Kahl

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Asher Chanan-Khan about current standards of care for Waldenstrom macroglobulinemia, as well as a clinical trial looking at a novel therapy.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Asher Chanan-Khan about the current standards of care for Waldenstrom macroglobulinemia, also known as WM.

WM is a rare, incurable disease. Its current standards of care available consist of Rituxan (rituximab), Imbruvica (ibrutinib) combinations or monotherapy in the first- and second-line setting. However, there are no treatments currently approved for the third line.

Chanan-Khan discussed these options, as well as a novel agent, CLR 131, that is being evaluated in a phase 2 study.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Related Content
Illustration of red blood cells and cancer cells.
December 13th 2024

‘Golden Bachelor’ Reveals Cancer Diagnosis, Ryne Sandberg’s Cancer Has Returned and More

Alex Biese Ashley Chan
From Gerry Turner announcing he has cancer to the return of a Chicago Cubs legend’s disease, here’s what’s happening in the cancer space this week.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of Dave Coulier.
December 4th 2024

Expert Explains Lymphoma After Dave Coulier's Diagnosis

Alex Biese
An expert from the CURE® advisory board explains the likely treatability of Dave Coulier’s non-Hodgkin lymphoma.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of blood cells.
October 29th 2024

FDA Expands Approval for Jylamvo to Children With Acute Lymphoblastic Leukemia

Darlene Dobkowski, MA
Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic leukemia, among other diseases.
Illustration of blood cancer cells.
July 24th 2024

Iopofosine I 131 Is Promising Across Waldenstrom’s Macroglobulinemia Types

Brielle Benyon
Eighty percent of patients with relapsed or refractory Waldenstrom’s macroglobulinemia responded to treatment with iopofosine I 131, researchers found.